Effects of glucosamine on proteoglycan loss by tendon, ligament and joint capsule explant cultures

Osteoarthritis and Cartilage

Volumn 16, Issue 12, 2008, Pages 1501-1508

  Ilic, M Z ^a   Martinac, B ^a   Samiric, T ^a   Handley, C J ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

Glucosamine; Joint capsule; Ligament; Proteoglycans; Tendon

Indexed keywords

GLUCOSAMINE; PROTEOGLYCAN; SULFATE;

ANIMAL TISSUE; ARTICLE; CATABOLISM; CELL METABOLISM; CONTROLLED STUDY; COW; DEGRADATION; DRUG EFFECT; EXPLANT; FLUOROGRAPHY; GEL ELECTROPHORESIS; JOINT CAPSULE; LIGAMENT; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; TENDON;

ANIMALS; CATTLE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; JOINT CAPSULE; LIGAMENTS, ARTICULAR; PROTEOGLYCANS; TENDONS; UP-REGULATION;

EID: 55349113600     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2008.04.026     Document Type: Article

References (59)

1. Hey N.J., Handley C.J., Ng C.K., and Oakes B.W. Characterization and synthesis of macromolecules by adult collateral ligament. Biochim Biophys Acta 1034 (1990) 73-80
2. Ilic M.Z., Carter P., Tyndall A., Dudhia J., and Handley C.J. Proteoglycans and catabolic products of proteoglycans present in ligament. Biochem J 385 (2005) 381-388
3. Kleftogiannis F., Handley C.J., and Campbell M.A. Characterization of extracellular matrix macromolecules from bovine synovial capsule. J Orthop Res 12 (1994) 365-374
4. Rees S.G., Flannery C.R., Little C.B., Hughes C.E., Caterson B., and Dent C.M. Catabolism of aggrecan, decorin and biglycan in tendon. Biochem J 350 Pt 1 (2000) 181-188
5. Samiric T., Ilic M.Z., and Handley C.J. Characterisation of proteoglycans and their catabolic products in tendon and explant cultures of tendon. Matrix Biol 23 (2004) 127-140
6. Vogel K.G., and Heinegard D. Characterization of proteoglycans from adult bovine tendon. J Biol Chem 260 (1985) 9298-9306
7. Benjamin M., and Ralphs J.R. Tendons and ligaments - an overview. Histol Histopathol 12 (1997) 1135-1144
8. Melrose J., Smith S.M., Appleyard R.C., and Little C.B. Aggrecan, versican and type VI collagen are components of annular translamellar crossbridges in the intervertebral disc. Eur Spine J (2007)
9. Wiberg C., Klatt A.R., Wagener R., Paulsson M., Bateman J.F., Heinegard D., et al. Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan. J Biol Chem 278 (2003) 37698-37704
10. Reginster J.Y. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum 56 (2007) 2105-2110
11. Bruyere O., Pavelka K., Rovati L.C., Gatterova J., Giacovelli G., Olejarova M., et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis Cartilage (2007) [OARS, Osteoarthritis Research Society]
12. Reginster J.Y., Deroisy R., Rovati L.C., Lee R.L., Lejeune E., Bruyere O., et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357 (2001) 251-256
13. Clegg D.O., Reda D.J., Harris C.L., Klein M.A., O'Dell J.R., Hooper M.M., et al. Glucosamine, chondroitin sulfate, the two in combination for painful knee osteoarthritis. N Engl J Med 354 (2006) 795-808
14. Towheed T.E., Maxwell L., Anastassiades T.P., Shea B., Houpt J., Robinson V., et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev (2005) CD002946
15. Uitterlinden E.J., Jahr H., Koevoet J.L., Jenniskens Y.M., Bierma-Zeinstra S.M., Degroot J., et al. Glucosamine decreases expression of anabolic and catabolic genes in human osteoarthritic cartilage explants. Osteoarthritis Cartilage 14 (2006) 250-257 [OARS, Osteoarthritis Research Society]
16. Varghese S., Theprungsirikul P., Sahani S., Hwang N., Yarema K.J., and Elisseeff J.H. Glucosamine modulates chondrocyte proliferation, matrix synthesis, gene expression. Osteoarthritis Cartilage 15 (2007) 59-68 [OARS, Osteoarthritis Research Society]
17. Abbaszade I., Liu R.Q., Yang F., Rosenfeld S.A., Ross O.H., Link J.R., et al. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family. J Biol Chem 274 (1999) 23443-23450
18. Rees S.G., Waggett A.D., Dent C.M., and Caterson B. Inhibition of aggrecan turnover in short-term explant cultures of bovine tendon. Matrix Biol (2007)
19. Tortorella M.D., Burn T.C., Pratta M.A., Abbaszade I., Hollis J.M., Liu R., et al. Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science 284 (1999) 1664-1666
20. Ilic M.Z., Vankemmelbeke M.N., Holen I., Buttle D.J., Clem Robinson H., and Handley C.J. Bovine joint capsule and fibroblasts derived from joint capsule express aggrecanase activity. Matrix Biol 19 (2000) 257-265
21. Imai K., Hiramatsu A., Fukushima D., Pierschbacher M.D., and Okada Y. Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J 322 Pt 3 (1997) 809-814
22. Kashiwagi M., Enghild J.J., Gendron C., Hughes C., Caterson B., Itoh Y., et al. Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem 279 (2004) 10109-10119
23. Monfort J., Tardif G., Reboul P., Mineau F., Roughley P., Pelletier J.P., et al. Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther 8 (2006) R26
24. Sandy J.D., Westling J., Kenagy R.D., Iruela-Arispe M.L., Verscharen C., Rodriguez-Mazaneque J.C., et al. Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4. J Biol Chem 276 (2001) 13372-13378
25. Gao G., Westling J., Thompson V.P., Howell T.D., Gottschall P.E., and Sandy J.D. Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem 277 (2002) 11034-11041
26. Ilic M.Z., Martinac B., and Handley C.J. Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage. Osteoarthritis Cartilage 11 (2003) 613-622 [OARS, Osteoarthritis Research Society]
27. Sandy J.D., Gamett D., Thompson V., and Verscharen C. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine. Biochem J 335 Pt 1 (1998) 59-66
28. Sandy J.D., Thompson V., Verscharen C., and Gamett D. Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid. Arch Biochem Biophys 367 (1999) 258-264
29. Riley G. The pathogenesis of tendinopathy. A molecular perspective. Rheumatology 43 (2004) 131-142
30. Scott A., Lian O., Roberts C.R., Cook J.L., Handley C.J., Bahr R., et al. Increased versican content is associated with tendinosis pathology in the patellar tendon of athletes with jumper's knee. Scand J Med Sci Sports (2007)
31. Campbell M.A., Winter A.D., Ilic M.Z., and Handley C.J. Catabolism and loss of proteoglycans from cultures of bovine collateral ligament. Arch Biochem Biophys 328 (1996) 64-72
32. Samiric T., Ilic M.Z., and Handley C.J. Large aggregating and small leucine-rich proteoglycans are degraded by different pathways and at different rates in tendon. Eur J Biochem 271 (2004) 3612-3620
33. Handley C.J., and Lowther D.A. Extracellular matrix metabolism by chondrocytes. III. Modulation of proteoglycan synthesis by extracellular levels of proteoglycan in cartilage cells in culture. Biochim Biophys Acta 500 (1977) 132-139
34. Hascall V.C., and Kimura J.H. Proteoglycans: isolation and characterization. Meth Enzymol 82 Pt A (1982) 769-800
35. Winter A.D., Campbell M.A., Robinson H.C., and Handley C.J. Catabolism of newly synthesized decorin by explant cultures of bovine ligament. Matrix Biol 19 (2000) 129-138
36. Handley C.J., and Campbell M.A. Catabolism and turnover of proteoglycans. Meth Enzymol 144 (1987) 412-419
37. Ilic M.Z., Handley C.J., Robinson H.C., and Mok M.T. Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 294 (1992) 115-122
38. Munteanu S.E., Ilic M.Z., and Handley C.J. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures. Matrix Biol 21 (2002) 429-440
39. Gotte M., Kresse H., and Hausser H. Endocytosis of decorin by bovine aortic endothelial cells. Eur J Cell Biol 66 (1995) 226-233
40. Jones G.C., Corps A.N., Pennington C.J., Clark I.M., Edwards D.R., Bradley M.M., et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum 54 (2006) 832-842
41. Rees S.G., Curtis C.L., Dent C.M., and Caterson B. Catabolism of aggrecan proteoglycan aggregate components in short-term explant cultures of tendon. Matrix Biol 24 (2005) 219-231
42. Vankemmelbeke M.N., Holen I., Wilson A.G., Ilic M.Z., Handley C.J., Kelner G.S., et al. Expression and activity of ADAMTS-5 in synovium. Eur J Biochem 268 (2001) 1259-1268
43. Vankemmelbeke M.N., Ilic M.Z., Handley C.J., Knight C.G., and Buttle D.J. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "aggrecanase" activity. Biochem Biophys Res Commun 255 (1999) 686-691
44. Campbell M.A., Handley C.J., Hascall V.C., Campbell R.A., and Lowther D.A. Turnover of proteoglycans in cultures of bovine articular cartilage. Arch Biochem Biophys 234 (1984) 275-289
45. Ilic M.Z., Robinson H.C., and Handley C.J. Characterization of aggrecan retained and lost from the extracellular matrix of articular cartilage. Involvement of carboxyl-terminal processing in the catabolism of aggrecan. J Biol Chem 273 (1998) 17451-17458
46. Vogel K.G., Sandy J.D., Pogany G., and Robbins J.R. Aggrecan in bovine tendon. Matrix Biol 14 (1994) 171-179
47. Maroudas A., Bayliss M.T., Uchitel-Kaushansky N., Schneiderman R., and Gilav E. Aggrecan turnover in human articular cartilage: use of aspartic acid racemization as a marker of molecular age. Arch Biochem Biophys 350 (1998) 61-71
48. Lohmander L.S., Neame P.J., and Sandy J.D. The structure of aggrecan fragments in human synovial fluid. Evidence that aggrecanase mediates cartilage degradation in inflammatory joint disease, joint injury, osteoarthritis. Arthritis Rheum 36 (1993) 1214-1222
49. Hutchinson J.W., Tierney G.M., Parsons S.L., and Davis T.R. Dupuytren's disease and frozen shoulder induced by treatment with a matrix metalloproteinase inhibitor. J Bone Joint Surg 80 (1998) 907-908
50. Renkiewicz R., Qiu L., Lesch C., Sun X., Devalaraja R., Cody T., et al. Broad-spectrum matrix metalloproteinase inhibitor marimastat-induced musculoskeletal side effects in rats. Arthritis Rheum 48 (2003) 1742-1749
51. Burton-Wurster N., Liu W., Matthews G.L., Lust G., Roughley P.J., Glant T.T., et al. TGF beta 1 and biglycan, decorin, fibromodulin metabolism in canine cartilage. Osteoarthritis Cartilage 11 (2003) 167-176 [OARS, Osteoarthritis Research Society]
52. Gouze J.N., Gouze E., Popp M.P., Bush M.L., Dacanay E.A., Kay J.D., et al. Exogenous glucosamine globally protects chondrocytes from the arthritogenic effects of IL-1beta. Arthritis Res Ther 8 (2006) R173
53. Rajapakse N., Mendis E., Kim M.M., and Kim S.K. Sulfated glucosamine inhibits MMP-2 and MMP-9 expressions in human fibrosarcoma cells. Bioorg Med Chem 15 (2007) 4891-4896
54. Hausser H., Ober B., Quentin-Hoffmann E., Schmidt B., and Kresse H. Endocytosis of different members of the small chondroitin/dermatan sulfate proteoglycan family. J Biol Chem 267 (1992) 11559-11564
55. Yanagishita M., and Hascall V.C. Metabolism of proteoglycans in rat ovarian granulosa cell culture. Multiple intracellular degradative pathways and the effect of chloroquine. J Biol Chem 259 (1984) 10270-10283
56. Persiani S., Rotini R., Trisolino G., Rovati L.C., Locatelli M., Paganini D., et al. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulphate at therapeutic dose. Osteoarthritis Cartilage 15 (2007) 764-772 [OARS, Osteoarthritis Research Society]
57. Setnikar I., and Rovati L.C. Absorption, distribution, metabolism and excretion of glucosamine sulfate. A review. Arzneimittelforschung 51 (2001) 699-725
58. Huser C.A., and Davies M.E. Effect of a glucosamine derivative on impact-induced chondrocyte apoptosis in vitro. A preliminary report. Osteoarthritis Cartilage 16 (2008) 125-128 [OARS, Osteoarthritis Research Society]
59. Lippiello L. Collagen synthesis in tenocytes, ligament cells and chondrocytes exposed to a combination of glucosamine HCl and chondroitin sulfate. Evid Based Complement Alternat Med 4 (2006) 219-224